Aimmune therapeutics stock

View AIMT stock price today, real time quote with excellent interactive chart, get the latest alerts for Aimmune Therapeutics, Inc, with indicator levels, dividend and earnings details. Add a live AIMT stock price to your free portfolio. View a financial market summary for AIMT including stock price quote, trading volume, volatility, options volume, statistics, and other important company data related …

Oct 2, 2019 Shares of Aimmune Therapeutics (NASDAQ:AIMT), a company developing a peanut desensitization therapy, jumped 12% on Wednesday after  AIMT | Complete Aimmune Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Analyzing Aimmune Therapeutics (NASDAQ:AIMT) stock? View AIMT's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC  Dec 31, 2019 Get breaking news and analysis on Aimmune Therapeutics, Inc. (AIMT) stock, price quote and chart, trading and investing tools. Jan 5, 2020 Aimmune Therapeutics, Inc. (NASDAQ:AIMT) has been quite a sprightly stock lately, and it has a couple of key events coming up as well.

Find the latest Aimmune Therapeutics, Inc. (AIMT) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.

Aimmune Therapeutics, Inc. is a biopharmaceutical company developing oral immunotherapy treatments for food allergies. 08/11/2019 · AIMT, Aimmune Therapeutics Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines 06/12/2019 · Real time Aimmune Therapeutics (AIMT) stock price quote, stock graph, news & analysis. Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more. 09/01/2020 · Aimmune Therapeutics, Inc. Common Stock (AIMT) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets.

View detailed stock price information for Aimmune Therapeutics Inc. [AIMT:US] from TMXmoney including charting and last 25 trades.

Stock analysis for Aimmune Therapeutics Inc (AIMT:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company  Aimmune Stock Halted as FDA Considers Peanut Allergy Treatment · By Tony Owusu. Sep 13, 2019 10:50 AM EDT. Global Stocks Slide as Tech Sector Slump  See Aimmune Therapeutics price target based on 8 analysts offering 12 month price targets for Aimmune Therapeutics in the last 3 months. The average price  Dec 18, 2019 Aimmune Therapeutics, Inc. (NASDAQ:AIMT): AIMT, DERM and EXPI head a list of the stocks with impressive upside potential based upon 

Dec 9, 2019 For Aimmune Therapeutics Inc., the new 52-week high came on volume of 835,777. The stock has a float of 63.3 million shares and average 

Dr. Jayson Dallas, Aimmune Therapeutics CEO and president, joins 'The Exchange' to discuss the company's peanut allergy therapy, one of the first of its kind.Hashtag #aimmune na Twitteruhttps://twitter.com/hashtag/aimmune16. 10. 2017 uživatel @reutersBenHir tweetnul: „#Aimmune teams with #Regeneron, #Sanofi ..“ – přečtěte si, co říkají ostatní, a zapojte se do konverzace. Biopharma company’s immunotherapy drug wins key FDA vote, stock swings. View live Aimmune Therapeutics INC chart to track its stock's price action. Find market predictions, AIMT financials and market news. Aimmune is a clinical-stage biopharmaceutical company. Our mission is to improve the lives of people with food allergies. Aimmune Therapeutics' scientific advisory board members offer critical peer review to help plan and optimize our work.

Find the latest quotes for (Aimmune Therapeutics, Inc. Common Stock) (AIMT) as well as charts and news at Nasdaq.com.

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more. 09/01/2020 · Aimmune Therapeutics, Inc. Common Stock (AIMT) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets.

Aimmune Therapeutics develops treatments for food allergies (peanut, milk, and egg) using Codit, its proprietary approach to oral immunotherapy. View AIMT stock info; drug pipeline; latest news; SEC filings; articles; upcoming catalysts and more at BioPharmCatalyst. Overview of insider trading in Aimmune Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Aimmune Therapeutics, Inc. Dr. Jayson Dallas, Aimmune Therapeutics CEO and president, joins 'The Exchange' to discuss the company's peanut allergy therapy, one of the first of its kind.Hashtag #aimmune na Twitteruhttps://twitter.com/hashtag/aimmune16. 10. 2017 uživatel @reutersBenHir tweetnul: „#Aimmune teams with #Regeneron, #Sanofi ..“ – přečtěte si, co říkají ostatní, a zapojte se do konverzace. Biopharma company’s immunotherapy drug wins key FDA vote, stock swings. View live Aimmune Therapeutics INC chart to track its stock's price action. Find market predictions, AIMT financials and market news.